戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e impact of oxidation on the antioxidant and immunomodulating ability of FPH.
2 vants based on physiochemical properties and immunomodulating activities in a mouse model.
3 high-avidity neutralizing antibodies and (2) immunomodulating activities mostly including downregulat
4  organ of the human body and exerts profound immunomodulating activities.
5 xplain the outstanding anti-inflammatory and immunomodulating activity of JAK inhibitors currently us
6 gies could be used to deliver molecules with immunomodulating activity to the graft itself or to defi
7 suggesting that low-dose rituximab exerts an immunomodulating activity.
8 cyte coculture in the absence or presence of immunomodulating agent cyclosporine (3 or 30 ng/mL), dex
9  (1000 ng/mL); coculture with monocytes; the immunomodulating agent cyclosporine (Cys; 30 ng/mL); the
10 treated mice emphasized its usefulness as an immunomodulating agent for allergic fungal diseases.
11 tigated the effect of vesnarinone as a novel immunomodulating agent on CD4XL-induced T-cell apoptosis
12 lts indicate that cNK-2 is a potential novel immunomodulating agent rather than an antimicrobial agen
13 le-4-carboxamide-1-beta-D-ribofuranoside, an immunomodulating agent that activates AMP-activated prot
14  who initiated new treatment with a targeted immunomodulating agent.
15  86 cases (66.3%) received a cytotoxic or an immunomodulating agent.
16 cular Adverse Events With Antineoplastic and Immunomodulating Agents [EROCA]; NCT03530215).
17 rom fungal cell walls have potential uses as immunomodulating agents and vaccine adjuvants.
18                                              Immunomodulating agents are a new class of drugs that ch
19 mework for the design of potent and nontoxic immunomodulating agents derived from subglutinols.
20                                              Immunomodulating agents dexamethasone (Dex), IL-10, and
21 l (MSC)-derived exosomes are well recognized immunomodulating agents for cardiac repair, while the de
22  potent, and water-soluble JAK inhibitors as immunomodulating agents for topical ocular disposition.
23  have been shown to be the new generation of immunomodulating agents in transplantation tolerance ind
24 d considering the early use of a second-line immunomodulating agents or pulse intravenous methylpredn
25 g of Kupffer cells with liposomes containing immunomodulating agents such as butyrate may be a useful
26 ective and examine clinical trials utilizing immunomodulating agents to further elucidate the importa
27 ciation of cytotoxic, anti-inflammatory, and immunomodulating agents to treat patients with AID with
28 even when combining anti-inflammatory and/or immunomodulating agents with repigmenting agents.
29 ns during cancer immunotherapy that involves immunomodulating agents, and the pressing need for novel
30 apy, anti-angiogenic compounds, vaccines and immunomodulating agents, differentiation agents, cytotox
31 treated with different immunosuppressive and immunomodulating agents, followed by 1 to 3 cycles of ri
32 en with psoriasis who started treatment with immunomodulating agents, serious infections were infrequ
33 ion of standard therapy with newly developed immunomodulating agents, such as antibodies blocking cyt
34 ongitudinally, especially in the presence of immunomodulating agents, we prospectively evaluated whet
35 venile and adult DM, even in the presence of immunomodulating agents.
36 lion-$5366.2 million) for antineoplastic and immunomodulating agents.
37 lpha and IFN-gamma are cytokines with potent immunomodulating and anti-tumor activities.
38 red; clinical management varied but included immunomodulating and antiviral therapies.
39 pivotal role in the antiadhesive, prebiotic, immunomodulating, and antimicrobial activities along wit
40  doublet immunotherapy, combining DKN-01, an immunomodulating antibody targeting Dickkopf-related pro
41     Our findings provide a potentially novel immunomodulating approach against AA.
42 ibodies but the optimal roles of traditional immunomodulating as well as newer biologic therapies in
43 e of prime importance for the development of immunomodulating compounds.
44 okines IL-9 and IL-13, as well as additional immunomodulating cytokines, were significantly decreased
45 58 is the first lead compound in a series of immunomodulating decapeptides discovered through activit
46 ying mutations affecting several potentially immunomodulating domains.
47 3-Val4-Tyr5) is known for its activity as an immunomodulating drug, but with limited half-life in pla
48 ed in long term remission (LTR), those using immunomodulating drugs (LTR + imids) and those using onl
49 noglobulin as maintenance therapy, and newer immunomodulating drugs can be used in refractory cases.
50                   Several antithrombotic and immunomodulating drugs have been proposed as candidates
51                                    Targeting immunomodulating drugs to the MLN may thus be beneficial
52  in approvals occurred in antineoplastic and immunomodulating drugs, biologics, and orphan drugs.
53 with refractory disease may respond to other immunomodulating drugs, including anti-TNF-alpha antibod
54 in association with other therapies, such as immunomodulating drugs.
55           This capability could maximize the immunomodulating effect of IRE in synergy with follow-up
56       Opiates are known to exert a number of immunomodulating effects in vitro and in vivo, and we so
57                                        These immunomodulating effects may be responsible for clinical
58    The current preclinical study expands the immunomodulating effects of enteral nutrition as previou
59 e adult (LADA) is safe and suggests possible immunomodulating effects of GAD65.
60 ll discuss recent findings demonstrating the immunomodulating effects of macrophage interferon signal
61 ood, but observational data suggest that the immunomodulating effects of parasitic helminths might co
62 l for studying the mechanisms underlying the immunomodulating effects of therapeutic exosomes.
63  is the first study to compare the potential immunomodulating effects of these commonly used agents.
64 mediators, such as induction of ketogenesis, immunomodulating effects, and/or reduction of ICU-associ
65 w, we describe how radiotherapy, through its immunomodulating effects, represents a promising combina
66    Thus, probiotics LGG+Bb12 exert divergent immunomodulating effects, with enhanced Th1 responses to
67  is thought to have some proinflammatory and immunomodulating effects.
68 therapy, and has demonstrated anti-tumor and immunomodulating effects.
69  of innate immune cells through TLR triggers immunomodulating events that enhance cell-mediated immun
70 er, SOM induces the production of the potent immunomodulating factor alpha-MSH by TCR-stimulated prim
71 COX-2, and (interleukin) IL-8 as well as the immunomodulating factors IL-6, transforming growth facto
72  OS at 3 y was significantly improved in the immunomodulating formula group (81%; 95% CI: 67%, 89%) c
73 e possibility that this viral protein has an immunomodulating function and may explain the mechanism
74                                   The use of immunomodulating gene therapy in the treatment of malign
75 e cassette of adenovirus early region 3 (E3) immunomodulating genes in pancreatic beta cells.
76                   Therefore, inactivation of immunomodulating genes such as B13R or B22R represents a
77              Considering the crucial role of immunomodulating genes such as that encoding the trigger
78     B13R (SPI-2) and B22R (SPI-1) are two VV immunomodulating genes with sequence homology to serine
79    Furthermore, prolactin represents a novel immunomodulating hormone for the treatment of immunodepr
80 nicians must choose from among the available immunomodulating, immunosuppressive, and targeted immuno
81 ican adults provides further evidence of the immunomodulating impact of H. pylori on oral vaccine imm
82                                              Immunomodulating mAbs directed against immune cell targe
83 9 test result, immunocompromising condition, immunomodulating medication, comorbidities, health care
84 e patients and patients already treated with immunomodulating medications (treatment-exposed patients
85 is study, we examined the capabilities of an immunomodulating metalloprotease (IMPa) from Pseudomonas
86 tion of TAA mRNA together with mRNA encoding immunomodulating molecules is a promising vaccination st
87  nanoparticle-based STING agonists and other immunomodulating nanomedicines.
88                 Herein, a rational design of immunomodulating nanoparticles is demonstrated that can
89                                  Using these immunomodulating nanoparticles, the remarkable inhibitio
90 ether COVID-19 risk is higher among those on immunomodulating or suppressive agents and characterized
91                                      Chronic immunomodulating parasitic infections including schistos
92                   Further research into TLR7 immunomodulating pathways as a basis for effective immun
93                                          Two immunomodulating polysaccharides, poly-(1-6)-beta-glucot
94  to sensitize TNBCs to ICB by harnessing the immunomodulating potential of S. aureus, a breast-reside
95       Extracorporeal photopheresis (ECP), an immunomodulating procedure that treats pheresed blood wi
96  lysate of human airway bacteria with strong immunomodulating properties and an impeccable safety pro
97  gram-negative bacteria demonstrate numerous immunomodulating properties and are involved in the viru
98  features of certain CCR5 inhibitors such as immunomodulating properties and HIV-1 latency reversal p
99 dominantly produced by the adult kidney, has immunomodulating properties that are required for sponta
100 unoglobulin (IVIG) therapy, by virtue of its immunomodulating properties, and its influence on B-cell
101 at many commonly prescribed medications have immunomodulating properties, surprisingly little is know
102 including anticancer, anti-inflammatory, and immunomodulating properties.
103  is a polyclonal IgG preparation with potent immunomodulating properties.
104 the time of bronchoscopy and analyzed for 28 immunomodulating proteins via multiplex bead array or en
105 kade (ICB) by driving inflammasome-regulated immunomodulating pyroptosis in ARID1A-inactivated OCCCs.
106                                              Immunomodulating regulatory T-cell (Treg) therapy is a p
107 d clinical data suggests it may also play an immunomodulating role in cancers.
108                               We studied the immunomodulating role of BECs in a human ex vivo model o
109                Our data indicates a possible immunomodulating role of LdTyrRS in Leishmania infection
110 fectious diseases, including cell therapies, immunomodulating small molecule delivery, and next-gener
111                                          The immunomodulating supplement did not significantly improv
112 Moreover, brain-centered glucoregulatory and immunomodulating systems that mediate peripheral health
113        This study explored the effect of the immunomodulating tellurium compound ammonium trichloro (
114 ture studies, and evaluate proposed COVID-19 immunomodulating therapeutics.
115  of erythroid bursts in culture responded to immunomodulating therapies (sensitivity 96%, specificity
116 nists may be a strategy for developing novel immunomodulating therapies against cancer.
117                               Although these immunomodulating therapies are all orally administered,
118  trials of immunosuppression, antiviral, and immunomodulating therapies are needed.
119 idence-based treatment, but various systemic immunomodulating therapies are used.
120 yclosporine were the most promising systemic immunomodulating therapies for SJS/TEN.
121 -allergen conjugates, and anti-IL-5 as novel immunomodulating therapies in allergy.
122          However, the role of antifungal and immunomodulating therapies in patients with ABPA, ABPM,
123                                          New immunomodulating therapies may also have a role TED mana
124 ven in the absence of autoimmune diseases as immunomodulating therapies may be effective in shortenin
125     Overall, 28 patients responded to either immunomodulating therapies or drug withdrawal.
126 nonrandomized studies on therapies (systemic immunomodulating therapies or supportive care) for SJS/T
127 thought and may derive benefit from systemic immunomodulating therapies that modulate key drivers of
128                                   The use of immunomodulating therapies was common: intravenous immun
129 eripheral nerve and establish how a range of immunomodulating therapies, including current treatments
130 d therapies were supportive care or systemic immunomodulating therapies, including glucocorticosteroi
131 eral candidates for monitoring efficacies of immunomodulating therapies.
132 udies have also evaluated the roles of other immunomodulating therapies.
133 s), is unresponsive to immunosuppressive and immunomodulating therapies.
134  is some evidence that immunosuppressive and immunomodulating therapy are effective for chronic, viru
135 file suitable for clinical development as an immunomodulating therapy for MS, and has a low projected
136 n tested in clinical trials without a single immunomodulating therapy showing consistent benefit.
137 supporting the use of fludarabine as a novel immunomodulating therapy to TBI.SIGNIFICANCE STATEMENT T
138                                   The use of immunomodulating therapy to treat various cancers has be
139 ffective in patients who are unresponsive to immunomodulating therapy, such as interferon beta and gl
140                                      Despite immunomodulating therapy, the patient died of overwhelmi
141 den, costs, and potential adverse effects of immunomodulating therapy.
142 vere atopic dermatitis (AD) require systemic immunomodulating treatment to achieve adequate disease c
143 ohibited medication (eg, systemic biological immunomodulating treatment, live vaccines, or other inve
144 ; ear, nose, and throat infections (7%); and immunomodulating treatments (5%).
145 controlled trials (RCTs) evaluating systemic immunomodulating treatments for moderate-to-severe AD we
146           To provide an overview on possible immunomodulating treatments for SJS/TEN and estimate the
147  comprehensive overview on proposed systemic immunomodulating treatments for SJS/TEN, which is of gre
148 t of different messenger RNA-based vaccines, immunomodulating treatments, and prior severe acute resp
149 , have shown partial response to a number of immunomodulating treatments, but the search for more eff
150 iency virus; and 5.71 (95% CI 4.22-7.75) for immunomodulating treatments.
151 ancer; ear, nose, and throat infections; and immunomodulating treatments.
152 ence or absence of infection with a group of immunomodulating viruses, particularly cytomegalovirus.

 
Page Top